Vertex Pharmaceuticals

Most active this month

• Dell Technologies1044 filings
• CrowdStrike269 filings
• Seagate Technology213 filings
• DDODatadog134 filings
• eBay Inc.111 filings
• Alphabet102 filings

3 approvals or clearances and 0 recalls recorded by the FDA for this company and its listed subsidiaries.

Approvals and clearances

• Mar 27AlyftrekDrug approval · New use approved (efficacy supplement). Active ingredient: Deutivacaftor, Tezacaftor, Vanzacaftor Calcium
• Mar 27Trikafta (Copackaged)Drug approval · New use approved (efficacy supplement). Active ingredient: Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor
• Mar 27Trikafta (Copackaged)Drug approval · New use approved (efficacy supplement). Active ingredient: Elexacaftor, Ivacaftor, Tezacaftor, Ivacaftor

From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.

67 certified in FY2026 Q3, vs 64 a year earlier. 67 positions in total, median offered wage $124K a year.

Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.